Download curriculum vitae - Bucci Laser Vision

CURRICULUM VITAE
FRANK A. BUCCI, JR., M.D.
166 West Mt. Airy Road
Shavertown, PA 18708
1970 - 1974
Rollins College, Winter Park, Florida
B.A. Economics - Full Basketball Scholarship
1974 - 1976
Account Executive, Construction Materials Division, Lehigh Portland
Cement Company, Orlando, Florida
1976 - 1978
Cornell University, Robert Wood Johnson Graduate School of
Management, Ithaca, New York
M.P.A. in Health Care Administration
1978 - 1980
University of Florida, Gainsville, Florida
Post-Baccalaureate Premed Program (GPA 3.9)
1981 - 1985
Rutgers Medical School, Newark, New Jersey
M.D. awarded May, 1985
1985 - 1986
Jersey Shore Medical Center, Neptune, New Jersey
Transitional Resident
1986 - 1989
Albany Medical Center Hospital, Albany, New York
Resident in Ophthalmology
1989 - 1990
University of Minnesota, Minneapolis, Minnesota
Fellowship in Cornea and External Disease, Refractive Surgery, and Small
Incision Cataract Surgery (Drs. Lindstrom, & Holland)
1990 - 1992
Corneal Consultants of Ohio, Sylvania, Ohio
1992 - 1998
The Pugliese Eye Specialists, Kingston, PA
1995 - 2000
Adjunct Staff, Wills Eye Hospital, Philadelphia, PA
1998 - Present
Founder, Bucci Laser Vision Institute & Ambulatory Surgery Center
Wilkes-Barre, PA
2003 - Present
Founder, Chairman of the Board, and President, Hospice of the Sacred
Heart, Wilkes Barre, PA
2007 - Present
Founder and Partner, Instituto de Ojos Sacro Cuore, Miraflores,
Lima, Peru
2008 - Present
Senior Medical Director for Physician Recommended Nutriceuticals,
Plymouth Meeting, PA
1
Scholarships and Awards:
Full Four-Year Athletic Scholarship (Basketball)
Omicron Delta Kappa Leadership Award
Captain 1973-1974 NCAA Eastern Regional Basketball Champions
The 1986 Publication Award – Annual Publications Award
Competition, Jersey Shore Medical Center
Robert D. Reinecke Award 1988 (Outstanding Research by Resident in Ophthalmology)
Best Scientific Poster - Annual Meeting of Contact Lens Associates of Ophthalmology (CLAO),
January, 1990
Fisons Corporation Grant for Ophthalmic Contact Lens and Immunology Research - Annual Meeting of
Contact Lens Association of Ophthalmology (CLAO), January, 1992
Fisons Corporation Grant for Ophthalmic Contact Lens and Immunology Research - Annual Meeting of
Contact Lens Association of Ophthalmology (CLAO), January, 1993
Best Scientific Poster - Annual Meeting of Contact Lens Associates of Ophthalmology (CLAO),
January, 1994
Fisons Corporation Grant for Ophthalmic Contact Lens and Immunology Research - Annual Meeting of
Contact Lens Association of Ophthalmology (CLAO), January, 1994
Best Scientific Poster - Annual Meeting of Contact Lens Associates of Ophthalmology (CLAO),
January, 1995
Best Paper of Session - Annual Meeting of the American Society of Cataract and Refractive Surgery
(ASCRS) Symposium, San Diego, CA, April, 2007
Best Poster of Conference - Annual Meeting of the American Society of Cataract and Refractive
Surgery (ASCRS) Symposium, San Diego, CA, April, 2007
American Academy of Ophthalmology’s (AAO) Achievement Award, May, 2007
Speaker of the Day - Royal Hawaiian Eye 2008, Physicians Program, January 21, 2008
The Times Leader Health Care Hero, 2009
Governor Robert P. Casey Medal for a Lifetime of Service 2012
2
Organizations and Licensure:
Diplomate, American Board of Ophthalmology
Member, American Medical Association
Member, American Academy of Ophthalmology/International Society of Refractive Surgery
Member, Association for Research and Vision in Ophthalmology
Diplomate, National Board of Medical Examiners
Ocular Microbiology and Immunology Group
Contact Lens Association of Ophthalmology
American Society of Cataract and Refractive Surgeons
Castroviejo Cornea Society
Medical Advisory Board, Northeast PA Lions Eye Bank, Bethlehem, PA
Publications:
1.
Bucci, F.A., Jr. and Weiner, B.D.: The Pyogenic Granuloma. Arizona Medicine 41:794- 796,
1984.
2.
Bucci, F.A., Jr.: Self-Assessment Protocol. Journal American Academy Dermatology 15:26A,
27A, 35A, 1986.
3.
Bucci, F.A., Jr., Mesa, M., Schwartz, R.A., McNeil, G., Lambert, W.C.: Oral Lesions in
Lepromatous Leprosy. The Journal of Oral Medicine 42:4-6, 1987.
4.
Bucci, F.A., Jr., Savia, P.V., Jr., Mauriello, J.A., Jr.: Herpes Zoster Ophthalmicus. American
Family Physician 35:121-128, 1987.
5.
Bucci, F.A., Jr., Schwartz, R.A.: The Neurologic Complications of Herpes Zoster. American
Family Physician 37:185-192, 1988.
6.
Bucci, F.A., Jr., Krohel, G.B.: Optic Nerve Swelling Secondary to the Obstructive Sleep Apnea
Syndrome. American Journal of Ophthalmology 105:428-430, 1988.
7.
Bucci, F.A., Jr.: Oral Leprosy-Self Assessment Protocol, In: Problems in Dermatologic
Diagnosis and Management. W. Clark Lambert (Ed.), American Academy of Dermatology,
Evanston, Illinois, Pages 10-11, 14-15, 1988.
8.
Bucci, F.A., Jr., Gabriels, C.F., Krohel, G.B.: Successful Treatment of Postherpetic Neuralgia
with Capsaicin. American Journal of Ophthalmology 106:758, 1988.
3
9.
Bucci, F.A., Jr., Catalano, R.A., Simon, J.W.: Discordance of Accommodative Esotropia in
Monozygotic Twins. American Journal of Ophthalmology 107:84-85, 1989.
10.
Bucci, F.A., Jr., Dimitsopulos, T.M., Krohel, G.B.: Branch Retinal Artery Occlusion Secondary
to Percutaneous Transluminal Coronary Angioplasty. British Journal of Ophthalmology 73:221222, 1989.
11.
Beyer-Mears, A., Bucci, F.A., Jr., Delnal, M., Cruz, E.: Dietary Myo-Inositol Effect on Sugar
Cataractogensis. Pharmacology 39:59-68, 1989.
12.
Bucci, F.A., Jr., Holland, E.J.: Flavobacterium Meningosepticum Keratitis Successfully Treated
with Topical Trimethoprim-Sulfamethoxazole. American Journal of Ophthalmology 111:116118, 1991.
13.
Bucci, F.A., Jr., Lindstrom, R.L.: Total Pupillary Capture with Foldable Posterior Chamber
Intraocular Lens. Ophthalmic Surgery 22:414-415, 1991.
14.
Bucci, F.A., Jr., Holland, E.J., and Lindstrom, R.L.: Corneal Autografts for External Suture
Knots in Transsclerally Sutured Lens Implants. American Journal of Ophthalmology 112:353354, 1991.
15.
Bucci, F.A., Jr., Lopatynsky, M.O., Jenkins, P.L., Rickert, D.G., Gold, R.M.: The Acuvue
Disposable Contact Lens Versus the CSI Contact Lens in Patients with Giant Papillary
Conjunctivitis. American Journal of Ophthalmology 115:454-459, 1993.
16.
Chan, C.C., Cogan, D.G., Bucci, F.A., Jr., et.al.: An Anterior Corneal Dystrophy with
Dyscollagenosis (Reis-Bucklers type?). Cornea 12:451-460, 1993.
17.
Bucci, F.A., Jr., Tanner, J.B., Moody, K.J.: The Clinical Performance of the Surevue, Focus, and
CSI Daily Wear Lenses in Allergic and Normal Contact Lens Patients. CLAO Journal 20:159166, 1994.
18.
Bucci, F.A., Jr., Lopatynsky, M.O., Zloty, P.C.: The Clinical Performance of the Acuvue,
NewVues, and SeeQuence Disposable Contact Lenses in Patients with Giant Papillary
Conjunctivitis. International Contact Lens Clinics 22:80-86, 1995.
19.
Holland, E.J., Lee, R., Bucci, F.A., Jr., et. al.: Mottled Cyan Opacification of the Posterior
Cornea in Contact Lens Wearers. American Journal of Ophthalmology 119:620-626, 1995.
20.
Bucci, F.A., Jr., Tanner, J.B., Moody, K.J.: The Clinical Performance of the Optima Toric
Contact Lens Versus the CSI Toric Contact Lens. CLAO Journal 23:43-48, 1997.
21.
Bucci, F.A., Jr., Tanner, J.B., Moody, K.J.: Temporal Correlation of Tear IgE Levels with the
Onset of Symptoms in Patients Wearing Contact Lenses. ICLC Journal
22.
Bucci, F.A., Jr., Moody, K.J., Tanner, J.B., Klyce, S.: Corneal Topographic Analysis of RingShaped Irregular Astigmatism Caused by Annular Tinted Contact Lenses. CLAO Journal
23:161-167, 1997.
4
23.
Bucci, F.A., Jr., Myers, P.J., Tanner, J.B., Moody, K.J., Lopatynsky, M.O.: Clinical and
Overnight Corneal Swell Comparison of the 1-Day Acuvue Lens Versus the Medalist, Surevue,
Biomedics, and Acuvue Lenses. CLAO Journal 23:103-112, 1997.
24.
Bucci, F.A., Jr., O’Brien, T.P., Evans, R.E., Myers, P.J.: A Prospective Comparison of Four
Methods of Pre-Phacoemulsification Antibiotic Treatment Using Ofloxacin and
Ciprofloxacin. Investigative Ophthalmology & Visual Science 41,4:S768, 2000.
25.
Bucci, F.A., Jr.: Nutritional Amblyopia Resulting From Intra-Abdominal Surgery for
Obesity. (In Preparation)
26.
Bucci, F.A., Jr.: An In Vivo Study Comparing the Ocular Absorption of Levofloxacin and
Ciprofloxacin Prior to Phacoemulsification. American Journal of Ophthalmology 137:308-312,
2004.
27.
Bucci, F.A., Jr.: Consultation Section. Cataract Surgical Problem. Consultation on
Management of Case. Journal of Cataract & Refractive Surgery 31,12:2247-2253, 2005.
28.
Bucci, F.A., Jr., Waterbury, L., Amico, L.M.: Prostaglandin PGE2 Inhibition and Aqueous
Concentration of Ketorolac 0.4% (Acular LS) and Nepafenac 0.1% (Nevanac) in Patients
Undergoing Phacoemulsification. American Journal of Ophthalmology, 144:147-147, 2007
29.
Bucci, F.A., Jr., “In Vivo Pharmacokinetics and In Vitro Pharmacodynamics of
Nepafenac, Amfenac, Ketorolac, and Bromfenac”. Journal of Cataract and Refractive
Surgery, May 2008.
30.
Bucci, F.A., Jr.: Comparing Ketorolac 0.4% and Bromfenac 0.09% at Trough Dosing:
Aqueous Drug Absorption and PGE2 Levels, Journal of Cataract & Refractive Surgery,
August 2008
31.
Bucci, F.A., Jr.: Comparing Ketorolac 0.4% and Bromfenac 0.09% at Trough Dosing:
Aqueous Drug Absorption and PGE2 Levels Aqueous PGE2 at Trough NSAID Levels,
Advances in Therapy, March 2009
32.
Bucci, F.A., Jr.: Aqueous Prostaglandin E2 of Cataract Patients at Trough Ketorolac and
Bromfenac Levels After 2 Days Dosing, Advances in Therapy, May 2009
33.
Bucci , F. A., Jr.: “A randomized comparison of to-aqueous penetration of ketorolac
0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing
phacoemulsification, Current Medical Research and Opinion, November 2011.
34.
Bucci, F.A., Jr.: “Prostaglandin E2 Inhibition of Ketorolac 0.45%, Bromfenac 0.09%,
and Nepafenac 0.1% in Patients Undergoing Phacoemulsification, Advances in Therapy,
November 2011.
35.
Bucci, F.A., Jr., Antibacterial Efficacy of Prophylactic besifloxacin 0.6% and
moxifloxacin 0.5% in Patients Undergoing Cataract Surgery, Clinical Ophthalmology,
May 2015.
5
36.
Bucci, F.A., Jr., Pharmacokinetics and Aqueous Humor Penetration of levofloxacin 1.5%
and moxifloxacin 0.5% in Patients Undergoing Cataract Surgery, Clinical Ophthalmology,
May 2016.
37.
Bucci, F.A., Jr., The Effect of Oral Re-Esterified Omega-3 Nutrional Supplementation on Dry
Eyes, Cornea, In press.
Book Chapters
1.
Bucci, F.A., Jr.: Mastering Refractive IOLs – The Art and Science, Managing Patient
Expectations, New Jersey: Slack, Inc., 2008: 360-362.
2.
Bucci, F.A., Jr.: Mastering Refractive IOLs – The Art and Science, Multifocal IOL in
One Eye, New Jersey: Slack, Inc., 2008: 454-455.
3.
Bucci, FA., Jr.: Mastering Refractive IOLs – The Art and Science, Mini-RK:
Indications and Technique, New Jersey: Slack, Inc., 2008: 786-788.
4.
Bucci, FA., Jr.: Premium Cataract Surgery: A Step-by-Step Guide, Enhancements with
Micro-Radial Keratotomy/Astigmatic Keratotomy, Slack, Inc., 2012.
5.
Bucci, FA., Jr.: Premium Cataract Surgery: A Step-by-Step Guide, Enhancements with
Micro-Radial Keratotomy/Astigmatic Keratotomy, Slack, Inc., 2015.
Major Presentations:
1.
“Characterization of Mycobacterial Plasmid and Chromosomal DNA.”
Presented at the 14th Annual New Jersey Medical School Summer Research Symposium,
Newark, New Jersey, Feb. 22, 1982
2.
“Myo-Inositol Diminution of Diabetic Cataracts.”
Presented at the Annual Spring Meeting of the Association for Research in Vision and
Ophthalmology (ARVO), Sarasota, FL, May 7, 1985
3.
“Papilledema and Obstructive Sleep Apnea.”
Presented at the 9th Annual Albany Ophthalmology Update Albany, New York, May 19,
1987
4.
“The Deposit Resistant Hydrocurve Elite Soft Contact Lens and Giant Papillary Conjunctivitis –
A Preliminary Report.”
Presented at the 10th Annual Albany Ophthalmology Update, Albany, New York, June 18, 1988
5.
“The Deposit Resistant Hydrocurve Elite Soft Contact Lens and Giant Papillary
Conjunctivitis – A Final Report.”
Poster Presentation at the Annual Spring Meeting of the Association for Research in
Vision and Ophthalmology (ARVO), Sarasota, FL, May 3, 1989
6.
“The Acuvue Disposable Contact Lens and Giant Papillary Conjunctivitis - A
6
Preliminary Report.”
Presented at the 11th Annual Albany Ophthalmology Update, Albany, New York, June 3,
1989
7.
“The Acuvue Disposable Contact Lens Versus the CSI Lens in Giant Papillary Conjunctivitis – A
Final Report.”
Poster Presentation at the Annual Meeting of the Contact Lens Association of
Ophthalmology (CLAO), Las Vegas, Nevada, January 11, 1990 (Awarded Best Scientific
Poster)
8.
“The Effect of Intraincisional Thrombin on the Rate of Post-Operative Hyphema in
Cataract Surgery.”
Presented at the Annual Meeting of the American Society of Cataract and Refractive
Surgery (ASCRS), Los Angeles, CA, March 6, 1990
9.
“Post-Operative Corneal Swelling in Cataract Patients Using Collagen Shields As a
Surgical Adjunct.”
Presented at the Annual Meeting of the American Society of Cataract and Refractive
Surgery (ASCRS), Los Angeles, CA, March 6, 1990
10.
“Giant Papillary Conjunctivitis.”
Presented to the Minnesota Ophthalmological Society (M.O.S.), Minneapolis, MN, June 4,
1990
11.
“Giant Papillary Conjunctivitis and Soft Contact Lenses.”
Presented at CIBA Vision as a Private Consultant, Atlanta, Georgia, August 9, 1990
12.
“Refractive Surgery Update – Four Incision Radial Keratotomy and the Excimer Laser.”
Presented to the Northwest Ohio Ophthalmological Society (NOOS), Toledo, OH, March
10, 1991
13.
“The Surgical Correction of Myopia.”
Presented at the Multidisciplinary Conference of Flower Memorial Hospital, Sylvania, OH, June
11, 1991
14.
“Update in Refractive Surgery and the Treatment of Giant Papillary Conjunctivitis.”
Presented at the Annual Meeting of the Northeast Pennsylvania Optometry Society, Scranton,
PA, May 8, 1992
15.
“Corneal Transplantation and Refractive Surgery Updates.”
Presented at the Tenth Annual Ophthalmic Assistant Conference of The Pugliese Eye Specialists,
Nanticoke, PA, October 10, 1992
16.
“The Temporal Correlation of Tear IgE and the Onset of Symptoms in Contact Lens
Patients.”
Presented at the Annual Meeting of the Contact Lens Association of Ophthalmology (CLAO),
Las Vegas, NV, January, 1993
17.
“The Clinical Performance of the Surevue, Focus, and CSI Daily Wear Lenses in Allergic and
Normal Contact Lens Patients.”
7
Poster presentation at the Annual Meeting of the Contact Lens Association of Ophthalmology
(CLAO), Las Vegas, NV, January, 1994 (Awarded Best Scientific Poster)
18.
“Corneal Topographic Analysis of Ring-Shaped Irregular Astigmatism Caused by
Annular Tinted Contact Lenses.”
Poster presentation at the Annual Meeting of the Contact Lens Association of Ophthalmology
(CLAO), Las Vegas, NV, January, 1995 (Awarded Best Scientific Poster)
19.
“The Clinical Performance of the Optima Toric Contact Lens Versus the CSI Toric
Contact Lens.”
Presented at the Annual Meeting of the Contact Lens Association of Ophthalmology (CLAO),
Las Vegas, NV, January, 1995
20.
“Management of Eightball Hyphema, Iatrogenic Aniridia, and Traumatic Cataract
Following Severe Blunt Trauma in a Patient with Previous Mini-RK/AK.”
Presented at the International Society of Refractive Surgery (ISRS), Atlanta GA, October, 1995
21.
“Case Studies in Refractive and Cataract Surgery.”
Presented at the Orange County Ophthalmological Society Meeting, Irvine, CA, December, 1995
22.
“Clinical and Overnight Corneal Swell Comparison of the 1-Day Acuvue Lens Versus the
Medalist, Surevue, Biomedics, and Acuvue Lenses.”
Presented at the Annual Meeting of the Contact Lens Association of Ophthalmology (CLAO),
Las Vegas, NV, February, 1996
23.
“Update in Refractive Surgery.”
Presented at the Central Pennsylvania Ophthalmology Society Meeting, Camp Hill, PA,
March 7, 1996
24.
“Advances in Refractive Surgery.”
Presented at the Lehigh Valley Ophthalmic Society Meeting, Bethlehem, PA, March 12, 1996
25.
“Does Perioperative Topical Marcaine Reduce Symptoms Following Radial Keratotomy?
Presented at Mid-Summer Meeting of the International Society of Refractive Surgery (ISRS),
Minneapolis, MN, July, 1996
26.
“Acular Versus Voltaren for the Management of Post-Operative Symptoms Following Radial
Keratotomy.”
Presented at Mid-Summer Meeting of the International Society of Refractive Surgery
(ISRS), Minneapolis, MN, July, 1996
27.
“Overnight Corneal Swell Response of the Protek Bandage Contact Lens Compared to
the 1Day Acuvue, Acuvue, and Proclear Lenses.”
Presented at Mid-Summer Meeting of the International Society of Refractive Surgery (ISRS),
Minneapolis, MN, July, 1996
28.
“On-Axis 2-Incision Mini-RK: An Effective Treatment for Primary and Residual Low
Myopic Astigmastism.”
Presented at the Pre-Academy Meeting of the International Society of Refractive Surgery
(ISRS), Chicago, IL, November, 1996
8
29.
“The Protek Bandage Contact Lens – Prospective Evaluations of Post-RK Symptom
Management and Overnight Corneal Swell Analysis.”
Presented at the Contact Lens Association of Ophthalmology (CLAO), Las Vegas, NV, J
January, 1997
30.
“Comparison of Post-Phacoemulsification IOP in Patients Treated with Timoptic-XE,
Iopidine, Trusopt, and Intracameral Carbastat.”
Presented at Royal Hawaiian Eye, Maui, HI, January, 1997
31.
“Acular Versus Voltaren for the Management of Post-Operative Symptoms Following
Radial Keratotomy.”
Presented at Royal Hawaiian Eye, Maui, HI, January, 1997
32.
“Control of Intraocular Pressure Following YAG Laser – Xalatan vs Alphagan.”
Presented at Royal Hawaiian Eye, Maui, HI, January, 1998
33.
“A Clinical Comparison of the Acuvue Contact Lens vs the Precision UV Contact Lens.”
Presented at the Annual Meeting of the Contact Lens Association of Ophthalmology (CLAO),
Las Vegas, NV, January, 1998
34.
“Post-Op Control of Intraocular Pressure Following Phacoemulsification.”
Presented at Associazione Italiana di Facoemulsificazione, Rome, Italy, May, 1998
35.
“The Role of Non-Steroidal Inflammatory Drops in Laser Vision Correction.”
Presented at the 7th Annual Ocular Surgery News Symposium, New York, NY, October, 1998
36.
“Control of Post-Op Symptoms Following LASIK – Voltaren vs Acular PF.”
Presented at Royal Hawaiian Eye, Kona, HI, January, 1999
37.
“A Clinical Comparison of the Precision UV Contact Lens vs the Acuvue Contact Lens
with the Orientation Logo and UV Blocker.”
Presented at the Annual Meeting of the Contact Lens Association of Ophthalmology (CLAO),
Las Vegas, NV, January, 1999
38.
“Post-Operative Symptom Profiles – PRK vs LASIK.”
Presented at Wills Eye Hospital Future Focus Program, Philadelphia, PA, January, 1999
39.
“Control of Intraocular Pressure Following YAG Laser Capsulotomy – Iopidine 0.5% vs
Alphagan 0.2%.”
Presented at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium,
Seattle, WA, April, 1999
40.
“Comparison of Acular PF and Voltaren vs Placebo in the Control of Post-Op Symptoms
Following LASIK.”
Presented at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium,
Seattle, WA, April, 1999
41.
“Quantitative Analysis of Post-Operative Symptoms – PRK vs LASIK.”
9
Presented at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium,
Seattle, WA, April, 1999
42.
“Peri-Operative Medications for Maximizing Patient Satisfaction in LASIK”
Presented at the New York State Ophthalmological Society Meeting, New York, NY, September,
1999
43.
“NSAIDs and LASIK – What is the Optimum Dose?”
Presented at the 8th Annual Ocular Surgery News Symposium, New York, NY, October, 1999
44.
“Topical Non-Steroidals and LASIK – What is the Optimum Postop Dose?”
Presented at the Pre-Academy Meeting of the International Society of Refractive Surgery
(ISRS), Orlando, Fl, October 1999.
45.
“A Prospective Comparison of Four Methods of Pre-Phacoemulsification Antibiotic Treatment
Using Ofloxacin and Ciprofloxacin.”
Presented at Royal Hawaiian Eye, Maui, HI, January, 2000
46.
“The Optimum Use of NSAIDs with LASIK: A Review of Four Prospective Studies.”
Presented at Royal Hawaiian Eye, Maui, HI, January, 2000
47.
“A Prospective Comparison of Four Methods of Pre-Phacoemulsification Antibiotic Treatment
using Ofloxacin and Ciprofloxacin.”
Poster presentation at 2000 Wills Eye Hospital Annual Conference, Philadelphia, PA, March
2000
48.
“Diclofenac Sodium Ophthalmic Solution Versus Voltaren for the Control of Postoperative
Inflammation Following Phacoemulsification.”
Presented at 2000 Wills Eye Hospital Annual Conference, Philadelphia, PA, March, 2000
49.
“A Prospective Comparison of Four Methods of Pre-Phacoemulsification Antibiotic Treatment
Using Ofloxacin and Ciprofloxacin.”
Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2000
Annual Meeting, Fort Lauderdale, FL, April, 2000
50.
“Diclofenac Sodium Ophthalmic Solution Versus Voltaren for the Control of Postoperative
Inflammation Following Phacoemulsification.”
Presented at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium,
Boston, MA, May, 2000
51.
“A Prospective Comparison of Four Methods of Pre-Phacoemulsification Antibiotic Treatment
Using Ofloxacin and Ciprofloxacin.”
Poster presentation at the American Society of Cataract and Refractive Surgery (ASCRS)
Symposium, Boston, MA, May 2000
52.
“Rehabilitation of Progressive Hyperopia, Astigmatism and Iatrogenic Aniridia with H LASIK
and Astigmatic Keratotomy.”
Poster presentation at the Pre-Academy Meeting of the International Society of Refractive
Surgery (ISRS), Dallas, TX, October 2000
10
53.
Multivariant Regression Analysis of Flap Thickness Using the Hansatome Microkeratome for
Myopic LASIK.”
Presented at the Pre-Academy Meeting of the International Society of Refractive Surgery
(ISRS), Dallas, TX, October, 2000
54.
“Prospective Evaluations of Celluvisc Versus GenTeal Gel, Refresh Versus GenTeal, and
Refresh Plus Versus TheraTears During the First Month Following LASIK.”
Presented at the Pre-Academy Meeting of the International Society of Refractive Surgery
(ISRS), Dallas, TX, October, 2000
55.
“Optimum Control of Post Phaco Inflammation – Steroids, NSAIDs or Both: The Final Answer.”
Presented at Royal Hawaiian Eye, Koloa, Kauai HI, January, 2001.
56.
“The LASIK Dry Eye: Presentation, Pathophysiology and Treatment.”
Presented at Royal Hawaiian Eye, Koloa, Kauai HI, January, 2001
57.
“Prospective Evaluations of Celluvisc Versus GenTeal Gel, Refresh Versus GenTeal, and
Refresh Plus Versus TheraTears During the First Month Following LASIK.”
Poster presentation at Wills Eye Hospital 2001 Annual Conference, Philadelphia, PA, March,
2001
58.
“Multivariant Regression Analysis of Flap Thickness Using the Hansatome Microkeratome for
Myopic LASIK.”
Presented at Wills Eye Hospital 2001 Annual Conference, Philadelphia, PA, March, 2001
59.
“Do Silicone Punctal Plugs Impact Tear Lactoferrin Levels Following LASIK?”
Presented at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium,
San Diego, CA, April, 2001
60.
“Multivariant Regression Analysis of Flap Thickness Using the Hansatome Microkeratome for
Myopic LASIK.”
Presented at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium,
San Diego, CA, April, 2001
61.
“Prospective Evaluations of Celluvisc Versus GenTeal Gel, Refresh Versus GenTeal, and
Refresh Plus Versus TheraTears During the First Month Following LASIK.”
Poster presentation at the American Society of Cataract and Refractive Surgery (ASCRS)
Symposium, San Diego, CA, April, 2001
62.
Rehabilitation of Progressive Hyperopia, Astigmatism, Iatrogenic Aniridia, and Traumatic
Cataract with LASIK and AK Following Mini-RK and Severe Blunt Trauma.”
Poster presentation at the American Society of Cataract and Refractive Surgery (ASCRS)
Symposium, San Diego, CA, April, 2001
63.
“Prospective Evaluations of Celluvisc Versus GenTeal Gel, Refresh Versus GenTeal, and
Refresh Plus Versus TheraTears During the First Month Following LASIK.”
Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2001
Annual Meeting, Fort Lauderdale, FL, April, 2001
64.
“Do Silicone Punctal Plugs Impact Tear Lactoferrin Levels Following LASIK?”
11
Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2001
Annual Meeting, Fort Lauderdale, FL, April, 2001
65.
“The Effect of Silicone Punctal Plugs on Tear Lactoferrin Following LASIK?”
Poster presentation at the Pre-Academy Meeting of the International Society of Refractive
Surgery (ISRS), New Orleans, LA, November, 2001
66.
“Myopic Refractive Lensectomy with the Array Multifocal Implant.”
Poster presentation at the Pre-Academy Meeting of the International Society of Refractive
Surgery (ISRS), New Orleans, LA, November, 2001
67.
“Hyperopic Refractive Lensectomy with the Array Multifocal IOL.”
Presented at the Pre-Academy Meeting of the International Society of Refractive Surgery
(ISRS), New Orleans, LA, November, 2001
68.
“An Objective Comparison of Acular Versus Vexol to Control Inflammation Following
Phacoemulsification.”
Poster presentation at the 2001 Annual Meeting of the American Academy of Ophthalmology
(AAO), New Orleans, LA, November, 2001
69.
“The Effect of Silicone Punctal Plugs on Tear Lactoferrin Following LASIK.”
Poster presentation at the 2001 Annual Meeting of the American Academy of Ophthalmology
(AAO), New Orleans, LA, November, 2001
70.
“The LASIK Dry Eye Update: Tear Lactoferrin, Punctal Plugs, Hinge Position, HydroEye and
More.”
Presented at Hawaii 2002, Waikoloa, HI, January, 2002
71.
An In Vivo Comparison of the Ocular Absorption of Levofloxacin versus Ciprofloxacin Prior to
Phacoemulsification.”
Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2002
Annual Meeting, Fort Lauderdale, FL, May, 2002
72.
Effect of Silicone Punctal Plugs on Tear Lactoferrin Following LASIK.”
Poster presentation at the American Society of Cataract and Refractive Surgery (ASCRS)
Symposium, Philadelphia, PA, June, 2002
73.
Myopic Refractive Lensectomy with the Array Multifocal Implant.”
Poster presentation at the American Society of Cataract and Refractive Surgery (ASCRS)
Symposium, Philadelphia, PA, June, 2002
74.
“Effect of HydroEye with Omega Fatty Acids on Tear Lactoferrin.”
Presented at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium,
Philadelphia, PA, June, 2002
75.
“Hyperopic Refractive Lensectomy with the Array Multifocal IOL.”
Presented at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium,
Philadelphia, PA, June, 2002
76.
“Dry Eye In LASIK: Preoperative Evaluation and Prevention.”
12
Presented at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium,
Philadelphia, PA, June, 2002
77.
The Role of Fluoroquinolones in the Prevention of Endophthalmitis.”
Presented at the 11th Annual Ocular Surgery News Symposium, New York, NY, September,
2002
78.
“Myopic Refractive Lensectomy with the Array Multifocal Implant.”
Presented at the Pre-Academy Meeting of the International Society of Refractive Surgery
(ISRS), New Orleans, LA, October, 2002
79.
“Prevention and Treatment of LASIK Dry Eye Patients.”
Presented at the Pre-Academy Meeting of the International Society of Refractive Surgery
(ISRS), New Orleans, LA, October, 2002
80.
“Refractive Lensectomy: The Array Multifocal Lens for the Correction of Myopia and
Hyperopia”.
Presented at Royal Hawaiian Eye, Maui, HI, January, 2003
81.
“Myopic and Hyperopic Refractive Lensectomy with the Array Multifocal Implant.” Poster
presentation at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San
Francisco, CA, April, 2003
82.
“The Ocular Absorption of Fluoroquinolone Antibiotics and the Prevention of Endophthalmitis.”
Poster presentation at American Society of Cataract and Refractive Surgery (ASCRS)
Symposium, San Francisco, CA, April, 2003
83.
“The Effect of Continuous Preop and Postop Oral Omega Fatty Acids (HydroEye) on Tear
Lactoferrin in Bilateral LASIK Patients.”
Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San
Francisco, CA, April, 2003
84.
“The Five Templates of LASIK Dry Eye – The Temporal Assessment and Treatment of Ocular
Surface Disease in LASIK Patients.”
Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San
Francisco, CA, April, 2003
85.
“The Effect of Preop Lid Scrubs and Levofloxacin On Eyelid and Conjunctival Cultures Prior To
Cataract Surgery.”
Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2003
Annual Meeting, Fort Lauderdale, FL, May, 2003
86.
“The Ocular Absorption of Fluoroquinolones and the Prevention of Endophthalmitis.” Presented
at the 8th Annual International Joint Meeting of SOI, OSN, AICCER and ISRS, Florence
Symposium 2003, Florence, Italy, May, 2003
87.
“A System for the Diagnosis and Treatment of LASIK Dry Eye.”
Presented at the 8th Annual International Joint Meeting of SOI, OSN, AICCER and ISRS,
Florence Symposium 2003, Florence, Italy, May, 2003
13
88.
“Myopic And Hyperopic Refractive Lensectomy with the Array Multifocal Implant.”
Poster presentation at the European Society of Cataract and Refractive Surgeons (ESCRS)
Conference, Munich, Germany, September, 2003
89.
“The Effect of Preop Lid Scrubs and Levofloxacin on Eyelid and Conjunctival Cultures Prior to
Cataract Surgery.”
Poster presentation at the European Society of Cataract and Refractive Surgeons (ESCRS)
Conference, Munich, Germany, September, 2003
90.
“Refractive Lensectomy with the Array Multifocal Implant in Myopes and Hyperopes.”
Presented at the Pre-Academy Meeting of the International Society of Refractive Surgery
(ISRS), Anaheim, CA, November, 2003
91.
“Effect of Preop Lid Scrubs and Fluoroquinolones on Eyelid and Conjunctival Cultures Prior to
Cataract Surgery.”
Presented at The Surgeon’s Fluoroquinolone Symposium, American Academy of
Ophthalmology (AAO), Anaheim, CA, November, 2003
92.
“Effect of Preop Lid Scrubs and Fluoroquinolones on Eyelid and Conjunctival Cultures Prior to
Cataract Surgery.”
Presented at Royal Hawaiian Eye, Kauai, HI, January, 2004
93.
“Long-Term Results of Hyperopic & Myopic Lensectomy with the Array Multifocal Implant.”
Presented at Royal Hawaiian Eye, Kauai, HI, January, 2004
94.
“A Comparison of Immediate Postop Aqueous Cultures in Phaco Patients Receiving
Gatifloxacin and Moxifloxacin Preoperatively.”
Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2004
Annual Meeting, Fort Lauderdale, FL, April, 2004
95.
“A Comparison of Conjunctival and Eyelid Cultures in Phaco Patients Receiving Gatifloxacin
and Moxifloxacin Preoperatively.”
Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2004
Annual Meeting, Fort Lauderdale, FL, April, 2004
96.
“Effect of Preoperative Lid Scrubs and Levofloxacin on Eyelid and Conjunctival Cultures Prior
to Cataract Surgery.”
Poster presentation at American Society of Cataract and Refractive Surgery (ASCRS)
Symposium, San Diego, CA, May, 2004
97.
“Refractive Lensectomy with the Array Multifocal Implant in Myopes and Hyperopes.”
Poster presentation at American Society of Cataract and Refractive Surgery (ASCRS)
Symposium, San Diego, CA, May, 2004
98.
“Aqueous, Eyelid and Conjunctival Cultures in Phacoemulsification Using Zymar and Vigamox
Preoperatively .”
Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San
Diego, CA, May, 2004
14
99.
“Effect of Preoperative Lid Scrubs and Levofloxacin on Eyelid and Conjunctival Cultures Prior
to Cataract Surgery.”
Presented at the 9th Annual International Joint Meeting of OSN, AICCER and ISRS, Italian
Society of Ophthalmology Meeting 2004, Naples, Italy, May, 2004
100.
“Refractive Lensectomy with the Array Multifocal Implant for Myopes and Hyperopes.”
Presented at the 9th Annual International Joint Meeting of OSN, AICCER and ISRS, Italian
Society of Ophthalmology Meeting 2004, Naples, Italy, May, 2004
101.
“Multivariant Regression Analysis of Flap Thickness Using the Amadeus Microkeratome for
Myopic LASIK.”
Poster presentation at the European Society of Cataract and Refractive Surgeons (ESCRS)
Conference, Paris, France, September 2004
102.
“Long-Term Follow-Up of Refractive Lensectomy With the Array Multifocal Implant in Myopes
and Hyperopes.”
Poster presentation at the European Society of Cataract and Refractive Surgeons (ESCRS)
Conference, Paris, France, September 2004
103.
“Acular LS Vs Acular in the Control of Inflammation Following Phacoemulsification.”
Presented at Royal Hawaiian Eye, Maui, HI, January, 2005
104.
“Multivariant Regression Analysis of Flap Thickness Using the Amadeus Microkeratome for
Myopic LASIK .”
Poster presentation at American Society of Cataract and Refractive Surgery (ASCRS)
Symposium, Washington, DC, April 2005
105.
“Acular, Acular LS, and Voltaren After Phacoemulsification as Mono Therapy and Combined
with Pred Forte .”
Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium,
Washington, DC, April, 2005
106.
“Comparison of Ketorolac 0.5%, Ketorolac and Diclofenac 0.1% Combined with
Prednisolone 1% on Aqueous Flare Following Cataract Surgery.”
Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2005
Annual Meeting, Fort Lauderdale, FL, May, 2005
107.
“Prophylactic Strategies for the Prevention of Endophthalmitis.”
Presented at the 10th Annual International Joint Symposium of OSN and AICCER, Italian
Society of Ophthalmology, Florence, Italy, May, 2005
108.
“Strategies for the Prevention and Treatment of LASIK Dry Eye.”
Presented at the 10th Annual International Joint Symposium of OSN and AICCER, Italian
Society of Ophthalmology, Florence, Italy, May, 2005
109.
“Multivariant Regression Analysis of the Amadeus II Microkeratome Flap Thickness and a
Comparison of One Blade Vs. Two Blade Bilateral LASIK.”
Poster presentation at the European Society of Cataract and Refractive Surgeons (ESCRS)
Conference, Lisbon, Portugal, September 2005
15
110.
“Intermediate Near Visual Function in Bilateral Multifocal Cataract and Lensectomy Patients
Receiving ReZoom/ReSTOR vs. ReSTOR/ReSTOR.”
Poster presentation at the European Society of Cataract and Refractive Surgeons (ESCRS)
Conference, Lisbon, Portugal, September 2005
111.
“Combining IOLs: Early Results.”
Presented at 2nd Annual Refractive IOL Symposium, Las Vegas, NV, December, 2005
112.
“Multifocal IOLs ReZoom/ReSTOR vs. ReSTOR/ReSTOR.”
Presented at Royal Hawaiian Eye, Maui, HI, January, 2006
113.
“NSAID Update Acular LS vs. Nevanac.”
Presented at Johns Hopkins 28th Annual Current Concepts in Ophthalmology-P.R., San Juan,
Puerto Rico, February, 2006
114.
“Multifocal IOLs ReZoom/ReSTOR vs. ReSTOR/ReSTOR.”
Presented at Johns Hopkins 28th Annual Current Concepts in Ophthalmology-P.R., San Juan
Puerto Rico, February, 2006
115.
“Multivariant Regression Analysis of the Amadeus II Microkeratome Flap Thickness and a
Comparison of One Blade vs. Two Blade Bilateral LASIK.”
Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San
Francisco, CA, March, 2006
116.
“Multifocal IOLs: ReZoom/ReSTOR vs. ReSTOR/ReSTOR.”
Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San
Francisco, CA, March, 2006
117.
“Intermediate and Near Visual Function in Bilateral Multifocal Cataract and Lensectomy
Patients Receiving ReZoom/ReSTOR vs. ReSTOR/ReSTOR.”
Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2006
Annual Meeting, Fort Lauderdale, FL, April, 2006
118.
“Aqueous PGE2 Inhibition of Ketorolac Tromethamine 0.4% vs. Nepafenac 0.1% In
Patients Undergoing Phacoemulsification.”
Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2006
Annual Meeting, Fort Lauderdale, FL, April, 2006
119.
“A Comparison of Postoperative Inflammation (Flare) Following Routine Phacoemulsification
When Using Ketorolac Tromethamine 0.4% vs. Nepafenac 0.1%.”
Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2006
Annual Meeting, Fort Lauderdale, FL, April, 2006
120.
“Prophylactic Strategies for the Prevention of Endophthalmitis.”
Presented at the 13th Annual Meeting of the Canadian Society of Cataract Refractive Surgery,
Montreal, Canada, April, 2006
121.
“Intermediate and Near Visual Function in Bilateral Multifocal Cataract and Lensectomy
Patients Receiving ReZoom/ReSTOR vs. ReSTOR/ReSTOR.”
16
Presented at the 13th Annual Meeting of the Canadian Society of Cataract Refractive Surgery,
Montreal, Canada, April, 2006
122.
“Prophylactic Strategies for the Prevention of Endophthalmitis.”
Presented at the 11th Annual International Joint Meeting of OSN, SOI, AICCER, and
ISRS/AAO, Rome, Italy, May, 2006-
123.
“Combining the ReZoom and ReSTOR Multifocal IOLs for Achieving Maximum
Patient Outcomes.”
Presented at the 11th Annual International Joint Meeting of OSN, SOI, AICCER, and
ISRS/AAO, Rome, Italy, May, 2006
124.
“Presbyopia-Correcting IOLs: Maximizing Patient Satisfaction and Spectacle Independence.”
Lecture at the Summer ASCRS Meeting, Boston MA, August, 2006
125.
“Multivariant Regression Analysis of the Amadeus II Microkeratome Flap Thickness and a
Comparison of One Blade vs. 2 Blade Bilateral LASIK.”
Presented at the XXIV Congress of ESCRS, London, September, 2006
126.
“Prophylactic Strategies for the Prevention of Endophthalmitis.”
Presented at Phillips Eye Institute’s 2006 Cataract Conference, Minneapolis, MN, October, 2006
127.
“NSAIDS: Optimizing Surgical Outcomes.”
Presented at Phillips Eye Institute’s 2006 Cataract Conference, Minneapolis, MN. October, 2006
128.
“Multifocal IOLs: Current Perspective.”
Presented at Phillips Eye Institute’s 2006 Cataract Conference, Minneapolis, MN, October, 2006
129.
“Intermediate and Near Visual Function in Bilateral Multifocal Patients Receiving
ReZoom/ReSTOR vs. ReSTOR/ReSTOR.”
Presented at American Academy of Ophthalmology (AAO), Las Vegas, NV, November , 2006
130.
“Spotlight on Management of Presbyopia.”
Presented at American Academy of Ophthalmology (AAO), Las Vegas, NV,
November , 2006
131.
“Intermediate and Near Visual Function in Bilateral Multifocal Cataract and Lensectomy
Patients Receiving ReZoom/ReSTOR vs. ReSTOR/ReSTOR.”
Presented at the Refractive IOL Symposium, Scottsdale, AZ, December, 2006
132.
“ReZoom/ReSTOR vs. ReSTOR/ReSTOR: Patient Satisfaction, Visual Outcomes and Spectacle
Independence.”
Presented at Royal Hawaiian Eye, Kauai, Hawaii, January, 2007
133.
“The Use of NSAIDs with Cataract & Lensectomy Surgery.”
Presented at the Ocular Drug & Surgical Therapy Update, Dana Point, CA,
February, 2007
134.
“Visual Function in Bilateral Lensectomy and Cataract Patients Receiving ReZoom/ReSTOR vs.
ReSTOR/ReSTOR:Long Term Follow-Up.”
17
Poster presentation at American Society of Cataract and Refractive Surgery (ASCRS)
Symposium, San Diego, CA, April, 2007
135.
“Micro RK/AK to Treat Residual Refractive Errors After Multifocal IOLs vs. Laser Vision
Correction and LRI.”
Poster presentation at American Society of Cataract and Refractive Surgery (ASCRS)
Symposium, San Diego, CA, April, 2007
136.
“Comparison of Aqueous Absorption and PGE2 Inhibition with Ketorolac 0.4%, Nepanenec
0.1% and Bromfenac 0.9% in Cataract Patients Treated Preoperatively.”
Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San
Diego, CA, April, 2007 (Awarded Best Paper of Session)
137.
“Aqueous Penetration of Ketorolac 0.4% Compared with Bromfenac 0.9% in Cataract Patients:
Peak and Trough Drug Concentration.”
Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2007
Annual Meeting, Fort Lauderdale, FL, April, 2007
138.
“Vaseline Vision Dysphotopsia and Explantation Rates of the ReSTOR and ReZoom Multifocal
Implants.”
Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2007
Annual Meeting, Fort Lauderdale, FL, April, 2007
139.
“Bilateral Multifocal Cataract and Lensectomy Patients Receiving ReZoom/ReSTOR vs.
ReSTOR/ReSTOR-Long Term Follow-Up.”
Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2007
Annual Meeting, Fort Lauderdale, FL, April, 2007
140.
“Vaseline Vision Dysphotopsia and Explantation Rates of the ReSTOR and ReZoom Multifocal
Implants.”
Presented at the 12th Annual International Joint Meeting of OSN, SOI, AICCER at the Italian
Society of Ophthalmology (SOI) Congress, Rome, Italy, May, 2007 - Keynote Address
141.
“Near and Intermediate Visual Outcomes in Diffractive/Diffractive vs. Refractive/Diffractive
Multifocal Lens Combination.”
Presented at the 12th Annual International Joint Meeting of OSN, SOI, AICCER at the Italian
Society of Ophthalmology (SOI) Congress, Rome, Italy, May, 2007
142.
“The Dynamics of the Preop Presbyopic Consultation.”
Presented at the Eye Center Conference, Columbus, OH, September 2007
143.
“Mixing Multifocal IOLs to Achieve Maximum Patient Satisfaction.”
Presented at the Eye Center Conference, Columbus, OH, September 2007
144.
“Treatment Strategies for Residual Refractive Errors and the Results of Unilateral
Multifocals.”
Presented at the Eye Center Conference, Columbus, OH, September 2007
145.
“Vaseline Vision Dysphotopsia” and Explantation of the ReSTOR and ReZoom Multifocal
Implants.”
18
Presented at the XXV Congress of ESCRS, Stockholm, Sweden, September 200
146.
“Micro RK/AK” for Correcting Residual Refractive Errors Following Presbyopic IOLs.”
Presented at the XXV Congress of ESCRS, Stockholm, Sweden, September 2007
147.
“Unilateral Implantation of the ReZoom and ReSTOR Multifocal IOLs” Presented at the
American Academy of Ophthalmology, New Orleans, LA, November 2007
148.
“ “Micro RK/AK” for Correcting Residual Refractive Errors Following Presbyopic
IOLs”, Poster Presentation American Academy of Ophthalmology, New Orleans, LA,
November 2007
149.
“Achieving Success with Multifocal IOLs: Clinical Results and Practical Pearls”,
Course Senior Instructor, American Academy of Ophthalmology, New Orleans, LA,
November 2007
150.
“Maximizing Patient Satisfaction with Presbyopia Correcting IOLs”, Presented at Sunday
Breakfast Seminar, Royal Hawaiian Eye, Waikoloa, HA, January 2008
151.
“Tailoring the Preoperative Interview for Presbyopic IOL Candidates”, Royal Hawaiian
Eye, Waikoloa, HA, January 2008
152.
“First 100 Days”, Hawaiian Eye – Subspecialty Saturday, Royal Hawaiian Eye,
Waikoloa, HA, January 2008
153.
“Tailoring the Preoperative Interview for Presbyopic IOL Candidates”, Nursing and
Allied Health Program, Royal Hawaiian Eye, Waikoloa, HA, January 2008
154.
“Staying in Step with Innovation”, Course presented at SECO International,
February 2008
155.
“When to Explant”, Presentation at 2008 Winter Cataract Refractive Invitational Summit,
Telluride, CO, February 2008
156.
“Tailoring the Preoperative Interview for Presbyopic IOL Candidates”, Presentation at
Advanced Medical Optics Bringing You the Future Meeting, Mont Tremblant, Canada,
February 2008
157.
“Multifocal IOL Selection for Achieving Patient Satisfaction”, Presentation at
Advanced Medical Optics Bringing You the Future Meeting, Mont Tremblant, Canada,
February 2008
158.
“Vaseline Vision Dysphotopsia/Treating Residual Refractive Error”, Presentation at
Advanced Medical Optics Bringing You the Future Meeting, Mont Tremblant, Canada,
February 2008
159
“The TECNIS Multifocal”, Presentation at the Aspen Invitational Refractive
Symposium, Aspen, CO, March 2008
160.
“Achieving High Levels of Patient Satisfaction with Multifocal and Accommodating
IOLS”, Presented at Ground Rounds Downstate Medical Center, New York,
19
March 2008
161.
“Conjunctival Goblet Cell Density Following Sequential Therapy with Artificial Tear
and Cyclosporine 0.05%”, Poster presentation at American Society of Cataract and
Refractive Surgery (ASCRS) Symposium, Chicago, IL, April 2008
162. “Achieving High Levels of Patient Satisfaction with Multifocal and Accommodating
IOLs”, Presented as course at American Society of Cataract and Refractive Surgery
(ASCRS) Symposium, Chicago, IL, April 2008
163.
“The 10 P’s of Correcting Presbyopia: Pearls for Maximizing Patient Satisfaction”
Presented at The IV International Congress of Refractive Surgery, Cataract and
Glaucoma, Lima, Peru, April 2008
164.
“Optimizing the Use of PCIOLs: Unilateral, Bilateral, Mix & Match”
Presented The IV International Congress of Refractive Surgery, Cataract and Glaucoma,
Lima, Peru, April 2008
165.
“A Comparison of Silcone Hydrogel vs. Specialty Dry Eye Contact Lenses in Previous
Dry Eye Patients with and without Restasis”, Poster presentation at Association for
Research in Vision and Ophthalmology (ARVO), 2008 Annual Meeting, Fort
Lauderdale, FL, May 2008
166.
“Visual Outcomes and Patient Satisfaction of Cataract and Refractive Lensectomy
Patients Receiving Bilateral ReZoom Multifocal Implants”, Poster presentation at
Association for Research in Vision and Ophthalmology (ARVO), 2008 Annual
Meeting, Fort Lauderdale, FL, May 2008
167.
“NSAIDs in Today’s Ophthalmology Climate”, Allergan External Disease Market
Guidance Program, Boston, MA- May 2008
168.
“Endophthalmitis Prevention”, Allergan External Disease Market
Guidance Program, Boston, MA- May 2008
169.
“Optimizing Outcomes in Refractive Surgery”, Allergan External Disease Market
Guidance Program, Boston, MA- May 2008
170.
“Alternatives for Correcting Residual Refractive Errors: Laser & Incisional”,
New York SOURCE Symposium, New York, NY – June 2008
171.
“Aqueous Prostaglandin E2 of Cataract Patients at Trough Ketorolac and
Bromfenac Levels After 2 Days Dosing” Presented at: ARVO Summer Eye
Research Conference (SERC), Monterey, CA – July 2008
172.
“Update on the Tecnis Multifocal IOL”, Summer Refractive Invitational Summit 2008,
Aspen, CO – July 2008
173.
“Unilateral Implantation of the ReZoom & ReSTOR Multifocal IOLs”,
Presented at the XXVI Congress of ESCRS, Berlin, Germany – September 2008
20
174.
“Tailoring the Presbyopic Consultation & Strategied for Achieving an Effective
Preoperative Interview”, Refractive IOL Symposium, Las Vegas, NV – September 2008
175.
“NSAIDs & Anti-Infectives Panel”, Corneal Health Roundtable, Ocular Surgery News
Symposium, New York, NY – October 2008
176.
“Achieving Success with Presbyopic Correcting IOLs”, The Montreal Eye Clinic’s 9th
Optometric Symposium, Montreal, Quebec – October 2008
177.
“Implantation of Presbyopic Correcting IOLs Post Keratorefractive Surgery in Cataract
and Lensectomy Patients”, American Academy of Ophthalmology, Atlanta, GA –
October 2008
178.
“Roadmap to Success with Multifocal IOLs”, Meeting Instruction Course, American
Academy of Ophthalmology, Atlanta, GA – October 2008
179.
“10 Pearls to Improve Outcomes with Advance Multifocal IOL Implantation”, American
Academy of Ophthalmology, Atlanta, GA – October 2008
180.
“Surgical Treatment of Presbyopia”, Focal Points: Clinical Modules for
Ophthalmologists, American Academy of Ophthalmology, Atlanta, GA – October 2008
181.
“Optimizing the Ocular Surface with Natural Triglyceride Omega 3 Fish Oils”,
Royal Hawaiian Eye, Maui, HA – January 2009
182.
“Optimizing the Ocular Surface with Natural Triglyceride Omega 3 Fish Oils”,
Nursing and Allied Health Program, Royal Hawaiian Eye , Maui, HA – January 2009
183.
Allergan Dry Eye Advisory Summit, Miami Beach, FL – February 2009
184.
“Unilateral Implantation of Presbyopic Correcting IOLs: Comparison of ReZoom,
ReSTOR, Cyrstalens 5.0, and Crystalens HD”, Poster presentation at American
Society of Cataract and Refractive Surgery (ASCRS) Symposium, 2009 Annual
Meeting, San Francisco - April 2009
185.
“Maximizing Patient Satisfaction with Presbyopic Correcting IOLs”, Course Instructor
JCAHPO/ASCRS Technicians & Nurses Program, ASCRS 2009 Annual Meeting,
San Francisco, CA - April 2009
186.
“Ten Pearls to Improve Outcomes with Advanced Multifocal IOL Implantation”,
Co-Instructor Course Instructor, ASCRS 2009 Annual Meeting, San Francisco, CA April 2009
187.
“Bioavailability of Ethyl Ester Versus Triglyceride Omerga-3 Fatty Acids”,
Presented at American Society of Cataract and Refractive Surgery (ASCRS)
Symposium, San Francisco, CA - April 2009
188.
“Pharmacokinetics and Aqueous Humor Penetration”, Presented at Vistakon
Pharmaceuticals ASCRS Breakfast Symposia, ASCRS, San Francisco, CA - April 2009
21
189.
“The Pharmacokinetics and Aqueous Humor Penetration of Levofloxacin 1.5% and
Moxifloxacin 0.5% in Patients Undergoing Cataract Surgery, ARVO, May 2009
190.
“Achieving Clinical Success with the New TECNIS Multifocal”, Ocular Surgery News
New York, NY – September 2009
191.
“Clinical Pearls & Update on Custom Matching and Staged Implantation”, Ocular
Surgery News New York, NY – September 2009
192.
“Do YAG Capsulotomies in Eyes with a Crystalens Significantly Impact Spherical
Refraction and Near Visual Function?”, ISRS/AAO Refractive Surgery Subspecialty
Day, San Francisco, CA – October 2009
193.
“A Novel Pharmacokinetic Study Comparing Corneal Penetration of Levofloxacin 1.5%
and Moxifloxacin 0.5%”, New Insights into Corneal Protection, American Academy of
Ophthalmology, San Francisco, CA – October 2009
194. “Clinical Pearls & Update on Custom Matching and Staged Implantation”, Co-Instructor,
Roadmap to Success with Presbyopic IOLs, American Academy of Ophthalmology,
San Francisco, CA – October 2009
195.
“Tailoring the Presbyopic Consultation: Strategies for Achieving an Effective
Preoperative Interview”, Co-Instructor, American Academy of Ophthalmology,
San Francisco, CA – October 2009
196. “Clinical Pearls & Update on Custom Matching and Staged Implantation”, Co-Instructor
Presbyopia Correcting IOL’s: The Best Option, American Academy of Ophthalmology,
San Francisco, CA – October 2009
197.
“Mixing and Matching Presbyopia-Correcting IOLs”, Online course for the American
Academy of Ophthalmology O.N.E. program, San Francisco, CA – October 2009
198. “Achieving Practice and Patient Success in the New Age of Multifocal Lenses”,
Moderator Roundtable, Philadelphia, PA – November 2009
199. “Achieving Practice and Patient Success in the New Age of Multifocal Lenses”,
Moderator Roundtable, New York, NY – November 2009
200. "Effect of Postoperative Atropine,YAG Capsulotomy, Spherical Aberration,
Defocus, and Pupil Size on Near Visual Performances of Models of Blended
Hinged Accommodating IOLS", Nursing and Allied Health Program, Royal Hawaiian
Eye , Koloa, HA – January 2010
201. "Effect of Postoperative Atropine,YAG Capsulotomy, Spherical Aberration,
Defocus, and Pupil Size on Near Visual Performances of Models of Blended
Hinged Accommodating IOLS", Royal Hawaiian Eye , Koloa, HA – January 2010
202. "The Pharmacokinetics and Aqueous Humor Penetration of Levofloxacin 1.5% and
Moxifloxacin 05% in Patients Undergoing Cataract Surgery", The 5th International
Conference on Ocular Infections, Palm Beach, FL - February, 2010
22
203.
"Achieving Success with Presbyopic Correcting IOLs: Preoperative Counseling, IOL
Selection, and Treatment of Residual Refractive Error, Course Instructor, American
Society of Cataract and Refractive Surgery (ASCRS) Symposium, Boston, MA - April
2010
204. "Effect of Postoperative Atropine, YAG Capsulotomy, Spherical Aberration, Defocus, and
Pupil Size on Near Visual Performances of Two Models of Blended Aspheric Hinged
Accommodating IOLs, Presented at American Society of Cataract and Refractive Surgery
(ASCRS) Symposium, Boston, MA - April 2010
205. "Comparison of Staged Implantation Strategies with Multifocal and Accomodating IOLs
for Maximizing Patient Satisfaction, Presented at American Society of Cataract and
Refractive Surgery (ASCRS) Symposium, Boston, MA - April 2010
206.
"Aqueous PGE2 Inhibition of Ketorolac Tromethamine 0.45%, Bromfenac 0.09%, and
Nepafenac 0.1% in Patients Undergoing Phacoemulsification", Poster presentation at
Association for Research in Vision and Ophthalmology (ARVO), 2010 Annual Meeting,
Fort Lauderdale, FL, May 2010
207.
"Aqueous PGE2 Inhibition of Ketorolac Tromethamine 0.45%, Bromfenac 0.09%, and
Nepafenac 0.1% in Patients Undergoing Phacoemulsification, Poster presentation at
Association for Research in Vision and Ophthalmology (ARVO), 2010 Annual Meeting,
Fort Lauderdale, FL, May 2010
208. " Visual Performance and Patient Satisfaction When Mixing a TECNIS Multifocal
with a Crystalens", Presented at the XXVIII Congress of ESCRS, Paris, France –
September 2010
209. " Bilateral Visual Outcomes with the Combination of a Crystalens and TECNIS
Multifocal", E-Poster, ISRS/AAO Refractive Surgery Subspecialty Day, Chicago, IL
October 2010
210.
"Visual Performance and Patient Satisfaction When Mixing a Diffractive Multifocal
IOL with an Accommodating IOL", Royal Hawaiian Eye , Maui, HA – January 2011
211.
"Comparison of RBC Saturation withOmega-3 Oral Supplements", Electronic Poster,
Presented at American Society of Cataract and Refractive Surgery
(ASCRS) Symposium, San Diego, CA - March, 2011
212.
" Ketorolac vs. Bromfenac: A Review of 7 Prospective Randomized Studies Comparing
PGE2 Inhibition and Aqueous Penetration", Electronic Poster Presented at American
Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Diego, CA March, 2011
213.
"A
Comparison of Omega-3 RBC Saturation for Three Oral Supplements: Dry Eye
Omega Benefits vs. TheraTears Nutrition vs. Nature Made, Poster presentation at
Association for Research in Vision and Ophthalmology (ARVO), 2011 Annual Meeting,
Fort Lauderdale, FL, May 2011.
23
214.
" A Comparison of the Bioavailability by Red Blood Cell Saturation of Re-esterified
Triglyceride Omega-3s vs. Ethyl Ester Omega-3s presented as an ePoster at the
American Academy of Ophthalmology, Orlando, FL, October 2011.
215.
"The Art of Achieving Success With Presbyopic-Correcting Intraocular Implants: The
Consultation, the IOLs, and Correcting Residual Refractive Errors, Course Instructor,
American Academy of Ophthalmology, Orlando, FL, October 2011.
216.
"Tailoring the Presbyopic Consultation: Strategies for Achieving an Effective
Preoperative Interview", Royal Hawaiian Eye , HA – January 2012.
217.
"An
Outcomes Comparison of Bilateral vs. Mix & Match: What I have learned after
implanting 2600 Presbyopic Correcting IOLs ", HA - January 2012.
218.
"A Comparison of Bilateral Diffractive Multifocal to a Diffractive Multifocal Combined with a
Zonal-Refractive Multifocal IOL", American Society of Cataract and Refractive Surgery
(ASCRS) Symposium, Chicago 2012.
219.
"A Comparison of the Bioavailability by RBC Saturation of Re-esterified Triglyceride
Omega-3s vs. Ethyl Ester Omega-3s", American Society of Cataract and Refractive
Surgery (ASCRS) Symposium, Chicago 2012.
220.
"Visual Performance, Reading Speed, and Patient Satisfaction after Receiving Bilateral
Multifocal IOLs", American Society of Cataract and Refractive Surgery (ASCRS)
Symposium, San Francisco 2013.
221.
"The Pharmacokinetics and Aqueous Humor Penetration of Besifloxacin 0.6% and
Moxifloxacin 0.5% in Patients Undergoing Cataract Surgery", Poster presentation at
Association for Research in Vision and Ophthalmology (ARVO), Annual Meeting,
Seattle 2013.
222.
"A Comparison of Prophylactic Antibacterial Efficacy of Besifloxacin 0.6% versus
Moxifloxacin 0.5% at 1 hour and 3 days prior to Phacoemulsification", Poster presentation at
Association for Research in Vision and Ophthalmology (ARVO), 2013 Annual Meeting,
Seattle 2013.
223.
“Multivariate Analysis of Overall Bilateral Satisfaction vs. Preoperative and Outcome Data
of Patients Receiving Diffractive Multifocal Implants”, Royal Hawaiian Eye , HA,
January 2014.
224.
“Multivariate Analysis of Overall Bilateral Satisfaction vs. Preoperative and Outcome Data
of Patients Receiving Diffractive Multifocal Implants”, Nursing and Allied Health Program,
Royal Hawaiian Eye , HA – January 2014.
225.
“Antibacterial Susceptibility of Coagulase Negative Staph Before and After Prophylactic
Use of Besifloxacin and Moxifloxacin”, Poster presentation at Association for Research in
Vision and Ophthalmology Annual Meeting, Orlando (ARVO), 2014.
226. “Multivariate Regression Analysis of Overall Bilateral Patient Satisfaction in Patients
Receiving Bilateral TECNIS Multifocal Implants”, European Society of Cataract and
24
Refractive Surgeons Annual Meeting (ESCRS), London, 2014.
227.
“Multivariate Analysis of Overall Bilateral Satisfaction vs Preoperative and Outcome Data
of Patients Receiving Diffractive Multifocal Implants”, Electronic poster presentation,
International Society of Refractive Surgery Annual Meeting (ISRS), Chicago 2014.
228.
“Multivariate Analysis of Overall Bilateral Satisfaction vs. Preoperative and Outcome Data
of Patients Receiving Diffractive Multifocal Implants”, Royal Hawaiian Eye, HA, January 2015.
229.
“Effect of Oral Re-esterified Omega-3 Supplementation on Dry Eye Disease: Double-masked
Randomized, Multicenter, and Placebo-controlled Study”, Royal Hawaiian Eye, HA, January
2016.
230.
“A Comparison of the Frequency of Use of the Malyugin Ring® With and Without Intracameral
Phenylephrine & Ketorolac 1%/0.3% Injection at the Time of Routine Cataract Surgery”, ARVO, Seattle,
WA, May 2, 2016.
231.
“The Effect of Mesopic Pupil Size and IOL Centration on Overall Patient Satisfaction
with the TECNIS Multifocal IOL”, ASCRS, New Orleans, 2016.
232.
“Achieving Success with Presbyopic Correcting IOLs: Pre op Counseling, IOL Selection, and
Treatment of Residual Refractive Error”, Course Instructor, ASCRS, New Orleans, 2016.
Trade Periodical “Publications”
1.
Bucci, F.A., Jr.: Roundtable Participant. “Maximizing Success in Refractive Surgery”.
Ocular Surgery News. June 1997.
2.
Bucci, F.A., Jr.: Roundtable Participant. “Management of Ocular Inflammation:
Evaluating Current Treatment Options”. Ocular Surgery News. July 1997.
3.
Bucci, F.A., Jr.: Roundtable Participant. “Opportunities and Techniques in Improving
Cataract Patient Outcomes”. Ocular Surgery News Supplement. May 1999.
4.
Bucci, F.A., Jr.: Roundtable Participant. “Ocular Surface Rehabilitation”. CIBA
Vision Ophthalmics by The Willow Group, Inc. August 1999.
5.
Bucci, F.A., Jr.: Roundtable Participant. “Use of NSAIDs in LASIK”. Ophthalmology
Times. February 2000.
6.
Bucci, F.A., Jr.: Research Featured In: “One Drop of NSAID Immediately Following
LASIK is the Best Regimen”. Ocular Surgery News. April 2000.
7.
Bucci, F.A., Jr.: Research Featured In: “One Drop of NSAID Helps Post-LASIK
Relief”. Ophthalmology Times. May 2000.
8.
Bucci, F.A., Jr.: Research Featured In: “Surgeons Extrapolate the Best Prophylaxis Methods
from Studies”. Ocular Surgery News. July 2000.
25
9.
Bucci, F.A., Jr.: Research Featured In: “Post Cataract Combination Therapy”. EyeWorld. May
2001.
10.
Bucci, F.A., Jr.: Research Featured In: “Head Off Dry Eye Before Surgery - 10 Questions You
Must Ask Your LASIK Patients”. Optometric Management. May 2001.
11.
Bucci, F.A., Jr.: Research Featured In: “Nonsteroidal Anti-Inflammatory Drugs: Options and
Applications in Ophthalmic Use”. Ocular Surgery News. May 2001.
12.
Bucci, F.A., Jr.: Research Featured In: “Treat Dry Eye Aggressively with Non-Preserved Tears”.
Ocular Surgery News. September 2001.
13.
Bucci, F.A., Jr.: Research Featured In: “A Review of the ASCRS NSAIDs Survey Results”.
EyeWorld. September 2001.
14.
Bucci, F.A., Jr.: Research Featured In: “Plugs Benefit High-Risk Cases”. Ophthalmology Times.
August 2001.
15.
Bucci, F.A., Jr.: Research Featured In: “Treat Dry Eye Aggressively with Non-Preserved Tears”.
Ocular Surgery News. August 2001.
16.
Bucci, F.A., Jr.: Research Featured In: “Perioperative Prophylaxis – The Search for the
Surgeon’s Fluoroquinolone”. EyeWorld. November 2001.
17.
Bucci, F.A., Jr.: Research Featured In: “Dry Eye Treatment Can Elevate Lactoferrin Levels in
Tears Prior to Refractive Surgery”. Ocular Surgery News. February 2002.
18.
Bucci, F.A., Jr.: Research Featured In: “Update On Diagnosing Dry Eye”. Ophthalmology
Management. February 2002.
19.
Bucci, F.A., Jr.: Research Featured In: “Post-LASIK Dry Eye Can Be Managed Effectively
Surgeons Say”. Ocular Surgery News Europe/Asia-Pacific Edition. March 2002.
20.
Bucci, F.A., Jr.: Research Featured In: “At Issue Column-Management of LASIK Dry Eye”.
Ocular Surgery News. March 2002.
21.
Bucci, F.A., Jr.: Roundtable Participant. “Use of NSAIDs in LASIK”. Ophthalmology Times.
April 2002.
22.
Bucci, F.A., Jr.: Research Featured In: “Surgeon: Punctal Plugs Help Restore Tear Lactoferrin”.
Ocular Surgery News. April 2002.
23.
Bucci, F.A., Jr.: “Astigmatism, High Myopia, and the Array”. Cataract & Refractive Surgery
Today. April 2002.
24.
Bucci, F.A., Jr.: “Endophthalmitis Prophylaxis and the Corneal Penetration of Topical
Fluoroquinolones”. Cataract & Refractive Surgery Today. April 2002.
26
25.
Bucci, F.A., Jr.: Research Featured In: “Complications of Refractive Surgery”. EyeWorld. July
2002.
26.
Bucci, F.A., Jr.: Research Featured In: “Dealing with Dry Eye”. EyeWorld. June 2002.
27.
Bucci, F.A., Jr.: Co-author of Monograph: “Ophthalmic Therapeutics: The Surgeon’s
Fluoroquinolone”. Ocular Surgery News. May 2002.
28.
Bucci, F.A., Jr.: Co-author of Monograph: “Treating Ocular Surface Disease Through Medical
Therapy”. Ophthalmology Times. September 2002.
29.
Bucci, F.A., Jr.: Research Featured In: “Lensectomy with Multifocal IOL Renders Impressive
Visual Results”. Ocular Surgery News. November 2002.
30.
Bucci, F.A., Jr.: Research Featured In: “Preventing Postoperative Infection”. Cataract &
Refractive Surgery Today. November 2003.
31.
Bucci, F.A., Jr.: Co-author of Monograph: “The Surgeon’s Fluoroquinolone: Letting the Science
Speak for Itself”. Ocular Surgery News. November 2003.
32.
Bucci, F.A., Jr.: Research Featured In: “Omega Fatty Acid Supplements Useful Strategy Before
LASIK”. Ophthalmology Times. November 2003.
33.
Bucci, F.A., Jr.: Research Featured In: “A Dry Eye Regimen for Cold Weather?”. EyeWorld.
November 2003.
34.
Bucci, F.A., Jr.: Research Featured In: “Lid Scrubs Plus Levofloxacin a Potent Antimicrobial
Prophylaxis”. ESCRS Eurotimes. November 2003.
35.
Bucci, F.A., Jr.: Research Featured In: “Comprehensive Dry Eye Treatments”. Cataract &
Refractive Surgery Today. January 2004.
36.
Bucci, F.A., Jr.: Research Featured In: “Treating the Dry Eye: The Role of Artificial
Tears”. Refractive Eyecare For Ophthalmologists. June 2004.
37.
Bucci, F.A., Jr.: Research Featured In: “NSAIDs Steroids, or Both for Cataract Surgery?”.
EyeWorld. August 2004.
38.
Bucci, F.A., Jr.: Research Featured In: “Easing Surgical Recovery”. Ophthalmology
Management. September 2004.
39.
Bucci, F.A., Jr.: Research Featured In: “Options to Consider for Bed Hydration”. EyeWorld.
September 2004.
40.
Bucci, F.A., Jr.: Research Featured In: “Topical Antibiotic Prophylaxis”. Cataract & Refractive
Surgery Today. February 2005.
41.
Bucci, F.A., Jr.: Roundtable Participant. “NSAID Uses in Cataract and Refractive Surgery”.
Supplement to Ophthalmology Times. February 2005.
27
42.
Bucci, F.A., Jr.: Research Featured In: “A Strategy for Endophthalmitis Prophylaxis”. Refractive
Eyecare. November 2005.
43.
Bucci, F.A., Jr.: Cataract Surgery Phaco Pearls Participant. “Achieving a Watertight Incision”.
Cataract & Refractive Surgery Today. January 2006.
44.
Bucci, F.A., Jr.: Roundtable Participant. “Philosophy of Mixing IOLs for Presbyopia Correction
Spurs Debate”. Ocular Surgery News. January 2006.
45.
Bucci, F.A., Jr.: Roundtable Participant. “LASIK Infection Prophylaxis: A Roundtable
Discussion”. Review of Ophthalmology. February 2006.
46.
Bucci, F.A., Jr.: Featured In: “Highlights of ASCRS”. Ocular Surgery News. April 2006
47.
Bucci, F.A., Jr.: Featured In: Mixing & Matching vs. Bilateral IOLs”. Refractive Surgery
Quarterly. 2006.
48.
Bucci, F.A., Jr.: Featured In: “ASCRS Summer Refractive Congress Highlights New
Technologies”. Ocular Surgery News. September 2006.
49.
Bucci, F.A., Jr.: Featured In: “Patient Selection, Preoperative Evaluation Critical for Success”.
Ocular Surgery News Supplement. October 2006.
50.
Bucci, F.A., Jr.: Featured In: “Flap Thickness Formula Aids in Decision-Making”.
Ophthalmology Times. January 2007.
51.
Bucci, F.A., Jr.: Research Featured In: “Mixing & Matching IOLs”. Cataract & Refractive
Surgery Today Supplement. February 2007.
52.
Bucci, F.A., Jr.: Roundtable Participant. “IOL Options in 2007”. Cataract & Refractive Surgery
Today – Annual IOL Issue. February 2007.
53.
Bucci, F.A., Jr.: Waxy Vision and Selected Multifocal IOL;
Managing Patient Expectations, Ocular Surgery News, March 2007
54.
Bucci, F.A., Jr.: Research Featured In: “Studies Suggest Superiority of Ketorolac in Cataract
Surgery”. Special Section: ASCRS Cataract News – Ophthalmology Times July 2007.
55.
Chu, Y.R., Bucci, F.A., Jr., McDonald II, J.E., et. al.: “Refractive Lens Exchange”. Cataract &
Refractive Surgery Today. August 2007.
56.
Bucci, F.A., Jr.: Research Featured In: Endophthalmitis Should Not Overshadow Other Severe
Complications”. Ocular Surgery News. October 2007.
57.
Bucci, F.A., Jr.: “Mastering Preoperative Interviews”. Cataract & Refractive Surgery Today.
November/December 2007.
58.
Bucci, F.A., Jr.: “Roudtable Participant. “Attracting, Communicating, and Converting Patients to
Refractive IOLs”. Cataract & Refractive Surgery Today. November/December 2007.
28
59.
Bucci, F.A., Jr.: “Mixing and Matching with the ReZoom Multifocal: Best of Both Worlds?”.
EyeWorld. May / June 2008.
60.
Bucci, F.A., Jr.: A Multifocal with Mass Appeal: The Tecnis Multifocal IOL,
Cataract & Refractive Surgery Today, January 2009.
61.
Bucci, F.A., Jr.: Natural Triglycerides Omega-3s Out Perform Ethyl Ester Omegas,
Optimizes Dry Eye Treatment and ARMD Prevention, Ocular Surgery News,
June 2009.
62.
Bucci, F. A., Jr., Aqueous Prostaglandin E2 of Cataract Patients at Trough Ketorolac and
Bromfenac Levels After 2 days Dosing, Advances in Therapy, June 2009.
63.
Bucci, F.A., Jr., Corneal Aqueous Penetration: Fluoroquinoline Pharmacokinetic Study
Findings, ASCRS EyeWorld, August 2009.
64.
Bucci, F.A., Jr., Clinician's Corner, Focal Points, Clinical Modules for Ophthalmologists,
September, 2009.
65.
Bucci, F.A., Jr., Building a Presbyopic IOL Practice, Practice Management, Special to
Ophthalmology Times, October 2009.
66.
Bucci, F.A., Jr., Update on Mastering Refractive IOLs: Tools of the Trade, Premier
Surgeon, July/August 2010.
67.
Bucci, F.A., Jr., Methicillin Resistance of Staphylococcus Species Among Health Care
and Nonhealth Care Workers Undergoing Cataract Surgery, Clinical Ophthalmology,
December 2010.
68.
Bucci, F.A., Jr., Four Errors in Prescribing Antibiotics, Cataract and Refractive Surgery
Today, February 2011.
69.
Bucci, F.A., Jr., Omega-3 and Dry Eye: Looking at Science and Clinical Experience,
EyeWorld, October, 2012.
70.
Bucci, F.A., Jr., Talking NSAIDs for Phacoemulsification, EyeWorld, October, 2012.
71.
Bucci, F.A., Jr., The Differences in My Phaco Technique With Laser Cataract Surgery,
Cataract and Refractive Surgery Today Europe, October 2012.
72.
Bucci, FA, Jr., Upside Down Multifocal IOL, Cataract and Refractive Surgery Today,
January 2013.
29